The Intersection of Regulatory and Patent Exclusivities for the Life Sciences Industry: A Comparative Overview of American and European Schemes

July 3, 2020

Jonathan B. Roses

An article written by Jonathan Roses and Toby Simpson, partner at Hoffmann Eitle, titled "The intersection of regulatory and patent exclusivities for the life sciences industry: a comparative overview of American and European schemes " was published in The Pharma Letter. Read more (subscription required).